BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kramvis A. Challenges for hepatitis B virus cure in resource-limited settings in sub-Saharan Africa. Curr Opin HIV AIDS 2020;15:185-92. [PMID: 32141888 DOI: 10.1097/COH.0000000000000619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan S, Yu H, Yang Z, Qin Y, Ren J, Cheng S, Ren F, Law BYK, Wong VKW, Ng JPL, Zhou Y, He X, Tan M, Zhang Z, Chen J. Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity. Front Pharmacol 2022;13:837115. [DOI: 10.3389/fphar.2022.837115] [Reference Citation Analysis]
2 Bierhoff M, Rijken MJ, Yotyingaphiram W, Pimanpanarak M, van Vugt M, Angkurawaranon C, Nosten F, Ehrhardt S, Thio CL, McGready R. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation. Int J Equity Health 2020;19:156. [PMID: 32912268 DOI: 10.1186/s12939-020-01268-3] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jackson K, Gish RG. Point of Care Diagnostic Testing for Hepatitis B Virus. Curr Hepatology Rep 2020;19:245-53. [DOI: 10.1007/s11901-020-00531-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]